Department of Information Management, Chaoyang University of Technology, Taichung, Taiwan.
College of Computer and Information Engineering, Xiamen University of Technology, No. 600, Ligong Rd., Jimei District, Xiamen, Fujian, China.
J Healthc Eng. 2017;2017:4307508. doi: 10.1155/2017/4307508. Epub 2017 Oct 26.
Although a number of researchers have considered the positive potential of Clinical Decision Support System (CDSS), they did not consider that patients' attitude which leads to active treatment strategies or targets.
We adopted the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) published to propose an HbA1c target and antidiabetic medication recommendation system for patients. Based on the antidiabetic medication profiles, which were presented by the American Association of Clinical Endocrinologists (AACE) and American College of Endocrinology (ACE), we use TOPSIS to calculate the ranking of antidiabetic medications.
The endocrinologist set up ten virtual patients' medical data to evaluate a decision support system. The system indicates that the CDSS performs well and is useful to 87%, and the recommendation system is suitable for outpatients. The evaluation results of the antidiabetic medications show that the system has 85% satisfaction degree which can assist clinicians to manage T2DM while selecting antidiabetic medications.
In addition to aiding doctors' clinical diagnosis, the system not only can serve as a guide for specialty physicians but also can help nonspecialty doctors and young doctors with their drug prescriptions.
尽管许多研究人员已经考虑到临床决策支持系统(CDSS)的积极潜力,但他们并没有考虑到患者的态度会导致积极的治疗策略或目标。
我们采用美国糖尿病协会(ADA)和欧洲糖尿病研究协会(EASD)发布的建议,提出了 HbA1c 目标和糖尿病药物推荐系统,适用于患者。基于美国临床内分泌医师协会(AACE)和美国内分泌学会(ACE)提出的糖尿病药物概况,我们使用 TOPSIS 计算了糖尿病药物的排名。
内分泌科医生建立了十个虚拟患者的医疗数据来评估决策支持系统。系统表明 CDSS 表现良好,有用性为 87%,推荐系统适用于门诊患者。对糖尿病药物的评估结果表明,系统的满意度为 85%,可以帮助临床医生在选择糖尿病药物时管理 T2DM。
除了辅助医生的临床诊断外,该系统不仅可以作为专科医生的指南,还可以帮助非专科医生和年轻医生开具处方。